Current Drug Targets logo Bentham Science Publishers logo

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 5, Number 6, August 2004

< previous issue | all issues | next issue >

Book review

Review article

Posttranslational Modifications of Tau - Role in Human Tauopathies and Modeling in Transgenic Animals
pp. 503-515(13)
Authors: Feng Chen; Della David; Alessandra Ferrari; Jurgen Gotz

Cholesterol and Alzheimer's Disease: Clinical and Experimental Models Suggest Interactions of Different Genetic, Dietary and Environmental Risk Factors
pp. 517-528(12)
Authors: Kumar Sambamurti; Ann-Charlotte Granholm; Mark S. Kindy; Narayan R. Bhat; Nigel H. Greig; Debomoy K. Lahiri; Jacobo E. Mintzer

Cytokines in Neuroinflammation and Alzheimer's Disease
pp. 529-534(6)
Authors: Mathias Cacquevel; Nathalie Lebeurrier; Simon Cheenne; Denis Vivien

Metal and Inflammatory Targets for Alzheimer's Disease
pp. 535-551(17)
Authors: Jack T. Rogers; Debomoy K. Lahiri

bgr-Sheet Breakers for Alzheimer's Disease Therapy
pp. 553-558(6)
Authors: Bieler S.; Soto C.

Mitotic and Gender Parallels in Alzheimer Disease: Therapeutic Opportunities
pp. 559-563(5)
Authors: X. Zhu; K. M. Webber; G. Casadesus; A. K. Raina; H. G. Lee; M. Marlatt; A. Hartzler; C. S. Atwood; R. Bowen; G. Perry; M. A. Smith

A New Alzheimer's Disease Interventive Strategy: GLP-1
pp. 565-571(7)
Authors: Tracy A. Perry; Nigel H. Greig

The Role of Cytochrome P450 Enzymes in the Metabolism of Risperidone and Its Clinical Relevance for Drug Interactions
pp. 573-579(7)
Authors: R. Berecz; P. Dorado; A. D.L. Rubia; M. C. Caceres; I. Degrell; A. LLerena

Molecular Targets for Modulating Lung Inflammation and Injury
pp. 581-588(8)
Authors: R. T. Sadikot; J. W. Christman; T. S. Blackwell

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page